Published in Surg Endosc on May 05, 2007
Gastric cancer. Lancet (2009) 7.27
Sentinel node mapping during laparoscopic distal gastrectomy for gastric cancer. Surg Endosc (2008) 1.38
The role of laparoscopy for gastric surgery in the West. Gastric Cancer (2009) 1.15
Lymph node metastasis of gastric cancer. Cancers (Basel) (2011) 1.02
A multi-center study of using carbon nanoparticles to track lymph node metastasis in T1-2 colorectal cancer. Surg Endosc (2014) 0.87
Gastric lymphatic mapping for sentinel node biopsy by natural orifice transluminal endoscopic surgery (NOTES). Surg Endosc (2008) 0.84
Sentinel node navigation surgery for gastric cancer: Overview and perspective. World J Gastrointest Surg (2015) 0.83
What is the accuracy of sentinel lymph node biopsy for gastric cancer? A systematic review. Gastric Cancer (2012) 0.81
R0 resection in the treatment of gastric cancer: room for improvement. World J Gastroenterol (2010) 0.80
Sentinel lymph node in oesophageal cancer-a systematic review and meta-analysis. J Gastrointest Oncol (2014) 0.80
Controversies in the diagnosis and management of early gastric cancer. Chin J Cancer Res (2013) 0.80
Sentinel lymph node biopsy for gastric cancer: Where do we stand? World J Gastrointest Surg (2011) 0.79
Accurate, safe, and rapid method of intraoperative tumor identification for totally laparoscopic distal gastrectomy: injection of mixed fluid of sodium hyaluronate and patent blue. Surg Endosc (2013) 0.78
A decade in gastric cancer curative surgery: Evidence of progress (1999-2009). World J Gastrointest Surg (2012) 0.77
A multicenter study of using carbon nanoparticles to show sentinel lymph nodes in early gastric cancer. Surg Endosc (2015) 0.77
Sentinel node mapping during laparoscopic distal gastrectomy for gastric cancer. Surg Endosc (2009) 0.75
Sentinel node biopsy using blue dye and technetium99 in advanced gastric cancer: anatomical drainage and clinical application. Braz J Med Biol Res (2016) 0.75
Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg (1992) 9.97
Extended lymph-node dissection for gastric cancer. N Engl J Med (1999) 7.43
Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol (2006) 4.38
A randomized controlled trial comparing open vs laparoscopy-assisted distal gastrectomy for the treatment of early gastric cancer: an interim report. Surgery (2002) 3.75
An approach for the treatment of penile carcinoma. Cancer (1977) 3.22
Rate of detection of lymph node metastasis is correlated with the depth of submucosal invasion in early stage gastric carcinoma. Cancer (1999) 1.99
Radio-guided sentinel node detection for gastric cancer. Br J Surg (2002) 1.97
Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg (1996) 1.69
Laparoscopic gastrectomy with lymph node dissection for gastric cancer. Gastric Cancer (2006) 1.35
Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery (2003) 1.24
Can sentinel node navigation surgery reduce the extent of lymph node dissection in gastric cancer? Ann Surg Oncol (2001) 1.15
Recent advances in sentinel node navigation for gastric cancer: a paradigm shift of surgical management. J Surg Oncol (2005) 1.11
Sentinel lymph node mapping for gastric cancer using a dual procedure with dye- and gamma probe-guided techniques. J Am Coll Surg (2003) 1.09
Laparoscopic distal gastrectomy with regional lymph node dissection for gastric cancer. Surg Endosc (2005) 1.08
Laparoscopic sentinel node navigation achieved by infrared ray electronic endoscopy system in patients with gastric cancer. Surg Endosc (2006) 1.06
Sentinel node biopsy using dye and isotope double tracers in early gastric cancer. Ann Surg Oncol (2006) 0.93
Prognostic factors for early gastric cancer in France: Cox regression analysis of 332 cases. World J Surg (2004) 0.93
Predictive factors and timing for liver recurrence after curative resection of gastric carcinoma. Am J Surg (2003) 0.90
Interim results of sentinel node biopsy during laparoscopic gastrectomy: possible role in function-preserving surgery for early cancer. World J Surg (2006) 0.89
Sentinel lymph node mapping with technetium-99m colloidal rhenium sulfide in patients with gastric carcinoma. Am J Surg (2006) 0.85
Lymph node metastases in gastric cancer: correlation between new and old UICC TNM classification. Int Surg (2002) 0.82
Gastric cancer recurrence: clues for future approaches to avoiding an old problem. J Clin Gastroenterol (2001) 0.78
D1 versus D2 lymphadenectomy and volume versus training: ongoing debate in gastric cancer surgery. J Surg Oncol (2006) 0.75
Laparoscopic sentinel lymph node mapping for early gastric cancer. World J Surg (2005) 0.75
Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet (1993) 11.38
Twist is a potential oncogene that inhibits apoptosis. Genes Dev (1999) 3.14
High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol (1999) 2.80
Optical coherence tomography in pediatric patients: a feasible technique for diagnosing celiac disease in children with villous atrophy. Dig Liver Dis (2009) 2.69
bcl-2 expression in pleural and extrapleural solitary fibrous tumours. J Pathol (1997) 2.66
Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol (2000) 2.56
p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol (2001) 2.19
Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group. N Engl J Med (1996) 2.17
Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol (2001) 2.13
Pancreatic ductal abnormalities documented by secretin-enhanced MRCP in asymptomatic subjects with chronic pancreatic hyperenzymemia. Am J Gastroenterol (2009) 2.10
Frequency of post-ERCP pancreatitis in a single tertiary referral centre without and with routine prophylaxis with gabexate: a 6-year survey and cost-effectiveness analysis. Dig Liver Dis (2006) 2.02
CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol (2003) 2.01
Clear cell ("sugar") tumor of the lung is a lesion strictly related to angiomyolipoma--the concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC). Pathology (1994) 1.88
Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa. Ann Oncol (2006) 1.71
TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst (2012) 1.65
Laparoscopic treatment of advanced colonic cancer: a case-matched control with open surgery. Colorectal Dis (2013) 1.64
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Isolation of the elusive pig islet. Surgery (1990) 1.56
p53 Protein expression in nevi and melanomas. Arch Dermatol (1993) 1.44
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. Clin Cancer Res (1995) 1.39
Fibroepithelial tumor of the breast with digital fibroma-like inclusions in the stromal component. Case report with immunocytochemical and ultrastructural analysis. Am J Surg Pathol (1994) 1.38
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): a multifocal disease. Histopathology (1992) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene (1992) 1.30
Pancreatoduodenectomy with occlusion of the residual stump by Neoprene injection. World J Surg (1989) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia. Am J Pathol (1998) 1.24
Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle. Mucosal Immunol (2013) 1.22
Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas. Am J Clin Pathol (1994) 1.22
Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Histopathology (2004) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma. Leukemia (2007) 1.19
Expression of progesterone receptors in solid-cystic tumour of the pancreas: a clinicopathological and immunohistochemical study of ten cases. Virchows Arch A Pathol Anat Histopathol (1993) 1.18
Endoscopic ultrasound-guided application of a new hybrid cryotherm probe in porcine pancreas: a preliminary study. Endoscopy (2008) 1.17
Tumour suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasms. J Pathol (1992) 1.16
Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up. Hum Pathol (1996) 1.15
Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas. Mod Pathol (2009) 1.15
Clear cell tumor and angiomyolipoma. Am J Surg Pathol (1991) 1.14
Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up. Clin Cancer Res (1996) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Use of calretinin in the differential diagnosis of unicystic ameloblastomas. Histopathology (2001) 1.13
Low expression of p27 and low proliferation index do not correlate in hairy cell leukaemia. Br J Haematol (2000) 1.11
Prevalence of intestinal metaplasia in the distal oesophagus, oesophagogastric junction and gastric cardia in symptomatic patients in north-east Italy: a prospective, descriptive survey. The Italian Ulcer Study Group "GISU". Dig Liver Dis (2001) 1.11
Reduction of insulin resistance by combined kidney-pancreas transplantation in type 1 (insulin-dependent) diabetic patients. Diabetologia (1990) 1.10
Biliary cystadenoma: an uncommon cause of recurrent cholestatic jaundice. Am J Gastroenterol (1986) 1.09
Ghrelin-producing epsilon cells in the developing and adult human pancreas. Diabetologia (2008) 1.09
Ultraviolet-induced p53 mutations in atypical fibroxanthoma. Am J Pathol (1994) 1.08
Antibiotic treatment for low-grade gastric MALT lymphoma. Lancet (1994) 1.07
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Hemodynamic and metabolic impairment in acute pancreatitis. World J Surg (1981) 1.07
Calretinin expression in ameloblastomas. Histopathology (2000) 1.06
Emergency liver resection for ruptured hepatocellular carcinoma complicating cirrhosis. Hepatogastroenterology (1999) 1.06
p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene (1996) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival. Br J Cancer (1996) 1.04
Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67. Acta Neuropathol (1987) 1.04
Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy. Ann Oncol (2007) 1.04
Impact of previous abdominal surgery on the outcome of laparoscopic colectomy: a case-matched control study. Tech Coloproctol (2007) 1.04
Tumor suppressor genes and related molecules in leiomyosarcoma. Am J Pathol (1996) 1.03
Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication. Dig Liver Dis (2008) 1.01
mdm2 gene alterations and mdm2 protein expression in breast carcinomas. J Pathol (1995) 1.01
Basaloid squamous cell carcinoma of the head and neck: clinicopathological features and differential diagnosis. Ann Otol Rhinol Laryngol (1996) 1.01
Bax immunohistochemical expression in breast carcinoma: a study with long term follow-up. Int J Cancer (1998) 1.01
Fully covered self-expandable metallic stents in benign biliary strictures: a multicenter study on efficacy and safety. Endoscopy (2012) 1.01
Lack of feedback inhibition of insulin secretion in denervated human pancreas. Diabetes (1992) 1.01
Prep1 (pKnox1)-deficiency leads to spontaneous tumor development in mice and accelerates EmuMyc lymphomagenesis: a tumor suppressor role for Prep1. Mol Oncol (2010) 1.00
Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences. Virchows Arch (2001) 1.00
p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: genetic and prognostic implications. Int J Cancer (1992) 0.99
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
Salvage chemotherapy with mitomycin, docetaxel, and irinotecan (MDI regimen) in metastatic pancreatic adenocarcinoma: a phase I and II trial. Cancer Invest (2004) 0.99
Pancreatic cancer versus chronic pancreatitis: diagnosis with CA 19-9 assessment, US, CT, and CT-guided fine-needle biopsy. Radiology (1991) 0.98
[Methylated bases in t-RNA of cerebral tumors]. Tumori (1968) 0.98
Glial fibrillary acidic protein immunoreactivity in normal and diseased human breast. Virchows Arch A Pathol Anat Histopathol (1991) 0.98
Choroid plexus tumors. An immunocytochemical study with particular reference to the coexpression of intermediate filament proteins. Am J Pathol (1987) 0.97
Cytolytic mechanisms of intraepithelial lymphocytes in coeliac disease (CoD). Clin Exp Immunol (2000) 0.97
Expression of a highly conserved protein, p27BBP, during the progression of human colorectal cancer. Cancer Res (2000) 0.97
p53 protein expression in central nervous system neoplasms. J Clin Pathol (1992) 0.97
Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibodies. Gastroenterology (1999) 0.97
Prognostic significance of the histopathologic recognition of low- and high-grade components in stage I-II B-cell gastric lymphomas. Am J Surg Pathol (2001) 0.96
Epithelial stem cell exhaustion in the pathogenesis of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis (2010) 0.95
Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer. Cancer (1994) 0.95
p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function. Blood (1996) 0.94
A study of the presence of B. burgdorferi, Anaplasma (previously Ehrlichia) phagocytophilum, Rickettsia, and Babesia in Ixodes ricinus collected within the territory of Belluno, Italy. Vector Borne Zoonotic Dis (2006) 0.94
Molecular aberrations of the G1-S checkpoint in myxoid and round cell liposarcoma. Am J Pathol (1997) 0.94
MDM2 overexpression does not account for stabilization of wild-type p53 protein in non-Hodgkin's lymphomas. Blood (1995) 0.94
Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest (1998) 0.93
Factors affecting survival and long-term outcome in the cirrhotic patient undergoing hepatic resection for hepatocellular carcinoma. Eur J Surg Oncol (2000) 0.93
p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-up. Int J Cancer (2000) 0.92
Collagenous colitis: a case series with confocal laser microscopy and histology correlation. Endoscopy (2008) 0.92